News Summary

In a significant development, two Canadian patients with spinal cord injuries have received Neuralink brain implants, enabling them to control a computer with their thoughts. This marks the first clinical trial outside the United States to assess the safety and effectiveness of Elon Musk’s Neuralink wireless brain chip, initially introduced in 2020. Conducted at Toronto Western Hospital, the procedure was led by Dr. Andres Lozano. The patients, one from Ontario and the other from Alberta, could move a computer cursor almost immediately post-surgery. Neuralink’s technology involves implanting electrodes in the brain’s motor area to translate neuron signals into actions on external devices, bypassing physical movement. The trial aims to determine the technology’s safety and its impact on patients’ quality of life, monitoring for side effects like seizures or infections. The patients will be observed for at least a year, with the potential to enroll more participants. This preliminary trial could pave the way for broader applications, such as driving vehicles or operating wheelchairs.